• MCOA’s Q3 2021 revenue increased 731% year on year from $53,195 in Q3 2020 to $442,178 in Q3 2021
• The company attributed this growth to its recent acquisition of cDistro, one of the fastest-growing distributors in North America
• cDistro’s acquisition is part of a strategic shift as the company looks to expand into new areas within the cannabis industry
• MCOA expects another record-breaking quarter in Q4 2021 as it anticipates reporting a full quarter of revenue from VBF Brands Inc., its newly acquired cultivation facility in Salinas, California

Marijuana Company of America (OTC: MCOA), a diversified holding company looking to grow its business and further establish itself in the legalized cannabis THC, hemp, and cannabidiol (“CBD”) industries, recently reported the highest quarterly revenue in its history (https://ibn.fm/eReC0). As part of the financial results for three months ended September 30, 2021 (“Q3 2021”), the company reported $442,178 in revenue, up from $53,195 in revenue reported in Q3 2020. This represented a 731% year-on-year increase. In addition, the company’s gross profits grew by 297%, from $16,025 reported in Q3 2020 to $63,687 in the most recent quarter. “During the third quarter 2021, despite the fact that we have been in the midst of a global pandemic, the company produced the highest revenues in its history,” said MCOA CEO Jesus Quintero. “Our Q3 financial performance was strong and reflects our ability, despite being in a challenging environment, to execute on the strategy by diversifying within the Cannabis industry through strategic acquisitions along with organic growth.” MCOA attributes the growth in revenue and gross profits to its new acquisition of cDistro, a company that distributes CBD brands, smoke and vape shop-related products to wholesalers, c-stores, specialty retailers, and consumers in North America. Completed toward the end of Q2 2021, the acquisition positioned MCOA to take advantage of immediate revenue and provided a massive opportunity for the company to establish a significant market share in the specialty distribution space (https://ibn.fm/qa9VG). Notably, cDistro’s acquisition is part of several investments the company has made to enhance its value proposition as well as drive its expansion into new areas within the cannabis industry. In August this year, MCOA announced a strategic shift in its business strategy as it expands into the legalized cannabis THC industry (https://ibn.fm/cbzbx). This move was reflected by the direct investment interest in Natural Plant Extract (“NPE”), an operator of licensed cannabis manufacturing and distribution business in California; potential acquisitions; and THC-oriented strategic partnerships with Cannabis Global Inc and Eco Innovation Group. Moreover, MCOA also announced its financial results for the nine months ended September 30, 2021. Total revenues grew 127% to $493,988 in 2021 up from $217,972 in 2020. The company attributed this increase to $407,589 of product sales from cDistro. MCOA also recorded $12,581 in equipment lease revenues and $73,818 from the sale of organic, plant-based hempsmart(TM) products, including Smart Drops (CBD Drops), Neuro Smart (Patented Brain Pills), and Smart Cream (Pain Cream). “We are confident that the steps we are taking will enable us to maintain a growing strong position as we drive growth across the entire business and maximize value for our stakeholders over the long term. Our expectation is that we should have another record-breaking quarter in Q4 2021, since we will report a full quarter of revenue from [VBF Brands Inc.] our newly acquired cultivation facility in Salinas, California,” added Quintero. The company started out in 2015 as a research and development (“R&D”) company focused exclusively on CBD. However, according to CEO Jesus Quintero, who presented during the October Benzinga Cannabis Capital Conference (https://ibn.fm/eiWGY), MCOA has undergone “an exciting transition.” The company is currently expanding to become an incubator of cannabis business opportunities as it seeks to grow “more vertically than horizontally.” MCOA is also expanding itself in the international market with a presence in South America through its new subsidiaries, hempsmart Brazil and hempsmart Uruguay. For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com. NOTE TO INVESTORS: The latest news and updates relating to MCOA are available in the company’s newsroom at http://ibn.fm/MCOA

• MINDCURE plans to schedule a pre-IND meeting with the FDA for its Desire Project during Q1 2022 with a subsequent Phase 2 trial to begin Q3 2022
• The company expects that the GLP supply of ibogaine will be available for distribution to research partners in Q2 2022
• Information on MC-106 and MC-808, an expansion of MINDCURE’s drug pipeline, will be released during Q2 2022

As a member of the Digital Therapeutics Alliance, Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) delivers digital therapeutics (“DTx”) that are evidence-based interventions driven by high-quality software to prevent, manage, and treat medical disorders or diseases. DTx can be used independently or with other medications, devices, or therapies, to optimize outcomes and patient care. MINDCURE is a leader in advanced proprietary technology and research centered around psychedelics and is currently advancing multiple programs and products to this end. The attested progress and plans for the immediate future were detailed in an operational update regarding the strategic initiatives of the company’s operating segments – MINDCURE Research and MINDCURE Technology (https://ibn.fm/pjF4K). MINDCURE Research’s update included updates on both The Desire Project and Ibogaine. The company has completed its draft research protocol for the use of MDMA and psychotherapy to treat female hypoactive desire disorder (The Desire Project) and expects a pre-IND meeting with the FDA in Q1 2022 and a subsequent Phase 2 trial to commence in Q3 2022. Earlier in 2021, MINDCURE announced that it would begin chemical synthesis routes to produce fully synthetic ibogaine. In July 2021, MINDCURE applied for patents on two routes for full chemical synthesis and initiated the production of Good Laboratory Practice (“GLP”), leading to the production of Good Manufacturing Practice (“GMP”) ibogaine. The company expects to have a GLP supply available for its research partners in Q2 2022. In addition to The Desire Project and its ibogaine efforts, MINDCURE is continuing to explore its options to expand its drug pipeline. There are two candidate selection programs currently underway for what is internally known as MC-106 and MC-808. More information will be released in Q2 2022. MINDCURE Technology also released an update on its DTx technology, iSTRYM, and its release as a minimum viable product (“MVP”) into partner clinics across North America. Although North America is the largest market for DTx, the global market was valued at $3.4 billion in 2020 and is expected to grow at a CAGR of 31.4% to reach $13.1 billion by 2026 (https://ibn.fm/y2EVV). The market’s expansion can potentially bring multiple opportunities for growth for the company, given the iSTRYM’s capability to easily scale at a global level as a drug-agnostic digital tool and distribution platform. MINDCURE’s unique and diversified approach works with multiple touchpoints, including technology, research, and drug supply and partnerships. The distribution component of its platform was kicked off recently, via the company’s partnership with Awakn Life Sciences (NEO: AWKN) (OTCQB: AWKNF), a biotech company with clinical operations researching, developing, and delivering psychedelic medicine to treat addiction. Under the agreement, MINDCURE will leverage iSTRYM to distribute Awakn’s ketamine-assisted psychotherapy for Alcohol Use Disorder in the United States and Canada. For more information, visit the company’s website at www.MindCure.com. NOTE TO INVESTORS: The latest news and updates relating to MCURF are available in the company’s newsroom at http://ibn.fm/MCURF

• Global videogame revenue is expected to surge 20% to $179.7 billion in 2020
• DigiMax is entering booming space through its partnership with BearClaw Esports
• Agreement with BearClaw Esports brings a frictionless, nondisruptive adoption to a growing generation that desires and monetizes from technological advancement

As a result of the global pandemic, video games have emerged as a larger industry than sports and movies combined, according to MarketWatch (https://ibn.fm/vHJOO). Savvy companies are looking to enter the booming space, and DigiMax Global (CSE: DIGI) (OTC: DBKSF) has done exactly that with its new partnership with BearClaw Esports, introducing the gaming industry to its cryptocurrency expertise (https://ibn.fm/adAO7). Gaming and cryptocurrency may make the perfect marriage. The two sectors have much in common. Both have been perceived as “social outcasts,” with many thinking that gamers spend their days in a dark basement, wasting away their lives while cryptocurrency is often rejected as a valid form of currency. In fact, both industries are seeing growing legitimacy. “Videogames have grown to resemble competition-based, interactive movies, and the COVID-19 pandemic has propelled the industry to make more money than movies and North American sports combined,” reported MarketWatch earlier this year. “Global videogame revenue is expected to surge 20% to $179.7 billion in 2020, according to IDC data, making the videogame industry a bigger moneymaker than the global movie and North American sports industries combined.” In addition, both spaces rely on tech savvy individuals for their growth, with programming and code being key components for success as well as cybersecurity being a top priority. Both sectors have also established reputations for setting social trends, carefully leveraging expertise and know-how to connect and communicate with their deeply engaged users bases. For example, Twitch has 15 million daily users, presenting an incredible opportunity for engagement (https://ibn.fm/WWP9g) while Discord, an online community platform initially created for gamers to communicate with one another, has an estimated 140 million users every month and now has a significantly wider appeal (https://ibn.fm/tj6sv). With this backdrop, DigiMax is combining forces with BearClaw Esports. The new partnership will provide BearClaw’s community of streaming gamers and Esports followers with access to CryptoHawk AI products and information. “Esports gamers are well known for their affiliation with cryptocurrencies, with many gamers also using their computer hardware to mine and trade a wide variety of cryptocurrencies,” stated DigiMax, noting that BearClaw attracts more than 200,000 gamers and viewers per month through a variety of events. The company anticipates that combining the BearClaw gaming community with CryptoHawk AI will give BearClaw users to access to CryptoHawk AI for their personal use in trading various cryptocurrencies and allow them to benefit through the CryptoHawk AI affiliate program by referring new subscribers. In addition, introducing the BearClaw gaming community to the CryptoHawk AI predictions solution adds a considerable diverse expansion to the user-base while aligning the BearClaw community with the growing DigiMax partnership community. “The technological savviness and leadership of the gaming industry and its community have always been in the forefront of innovation and AI,” said DigiMax chief technology officer Thierry Hubert. “This is why this partnership and outreach with BearClaw Esports brings a frictionless and nondisruptive adoption to a growing generation that desires and monetizes from technological advancement.” The partnership with BearClaw is indicative of DigiMax’s mission to empower investors to safely invest in cryptocurrencies by harnessing the power of artificial intelligence. The company is committed to unlocking the potential of disruptive technologies by providing advanced financial, predictive, and cryptocurrency solutions across various verticals. DigiMax reveals actionable predictive insight across the financial and human world. For more information, visit the company’s website at www.DigiMax-Global.com. NOTE TO INVESTORS: The latest news and updates relating to DBKSF are available in the company’s newsroom at https://ibn.fm/DBKSF

• The pharmacy practice is undergoing an evolution that will see pharmacies play a more significant role in patient care
• Expanded pharmacy technology has allowed pharmacists to better document patient care and results, and Avricore is playing a central role in making this possible
• The company’s HealthTab(TM) platform supports multiple rapid, lab-accurate testing instruments, and acts as a network for exchanging and reporting data/results
• Point-of-care testing has numerous benefits, including improved outcomes and quality of life for patients, limiting the spread of infectious diseases, faster treatment, shorter recovery times, and relieving overworked personnel in primary care centers

Health diagnostics technology innovator, Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF), is committed to moving pharmacy forward. Through its flagship HealthTab(TM) platform, the company turns pharmacies into community diagnostic centers, enabling pharmacists to take on more responsibilities in primary health services. With the community pharmacy practice experiencing an important transformation that will alter how the public thinks of community pharmacists’ role, Avricore is playing a central role in promoting this paradigm shift. “Many factors are coinciding to set up community pharmacy for an exciting evolution that will continue to grow in the coming years,” reads an article from the October issue of the Pharmacy Times’ Pharmacy Careers publication (https://ibn.fm/ImrJS). “The business model of health care is rapidly changing as communities need their pharmacies to meet gaps in care. Meanwhile, pharmacy technology has expanded to allow pharmacists to better document patient care and outcomes.” On the pharmacy technology end of the factor-based spectrum is Avricore’s HealthTab platform. HealthTab supports several rapid, lab-accurate testing devices and acts as a network for data exchange and reporting. The integrated devices offer quick onsite results covering infectious diseases, such as COVID-19, influenza A & B, strep, and RSV, as well as chronic conditions, namely diabetes and heart disease (https://ibn.fm/8Qi0k). HealthTab then shares the data with the patients, doctors, and pharmacists, allowing them to track results to ensure targets are being met. Avricore’s system offers proper planning, setup, and execution of point-of-care testing (“POCT”) in pharmacies with a bevy of accompanying benefits. For example, rapid results from POCT can help limit the spread of infectious diseases and promote shorter recovery times, improved outcomes, a better quality of life, and faster treatment. Additionally, the availability of POCT services for infectious diseases at pharmacies would help relieve the overworked personnel and nurses at urgent care centers and primary care stations, especially with the ongoing COVID-19 pandemic (https://ibn.fm/Yon5M). In understanding the underlying advantages of the POCT infrastructure it has built, Avricore is growing its platform’s reach in Canada. Last month, the company announced it had expanded to Western Canada with the rollout of HealthTab in select Shoppers Drug Mart stores in British Columbia. “The launch in Shoppers Drug Mart pharmacies in Ontario has been very successful, and we are very happy to see the program lay the groundwork for expansion,” commented AVCR CEO Hector Bremner in an October 26 press release (https://nnw.fm/XDDhQ). (https://ibn.fm/5ssUA). “Having a real-time patient observation program reporting seamlessly across 3,000 kilometers is very unique and we are very proud to deliver this innovation.” Avricore’s HealthTab, which dovetails with the emerging industry trends in the pharmacy practice, is also capitalizing on the rapidly growing global POCT market. Global Market Insights expects the market size to reach $51.8 billion by 2027, representing a CAGR of more than 7.4% during the forecast period, which runs from 2021 (https://ibn.fm/HwCN7). For more information, visit the company’s website at www.AvricoreHealth.com. NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF

• Growth in the uranium mining market is attributable to increase in nuclear fuel spend, reports the Business Research Company
• Report also noted key factors in projected growth of space, which should reach $10.18 billion by 2020
• UUUU is the leading U.S. producer of uranium, the fuel for carbon- and emission-free nuclear energy, in the country

The uranium mining market is projected to reach nearly $10.18 billion next year, according to a Business Research Company report, which noted that the industry should see CAGR of 4.6% during the forecast period (https://ibn.fm/vvT93). Energy Fuels (NYSE American: UUUU) (TSX: EFR), the largest producer of uranium in the United States, is committed to playing a significant role in the growing market. “The growth in the uranium ore mining market is due to increase in nuclear fuel spend in countries such as Australia, Kazakhstan and Canada owing to increasing spend in the defense industry,” stated the report, which noted that the uranium mining market consists of sales of uranium ores and concentrates by entities that mine and beneficiate uranium-radium-vanadium ores. “However, the market for uranium ore mining is expected to face certain restraints from several factors such as interest rate increases, workforce issues and safety.” The report also observed that the global uranium mining market is based on type and geography, with types of deposits including volcanic-type uranium deposits, sandstone-type uranium deposits and carbonate-siliceous-pelitic rock type uranium deposits. Geographical categories include North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa with Asia-Pacific uranium mining market accounting for the largest share in the global uranium mining market. “The use of autonomous hauling systems trucks in the mining industry is significantly enhancing production efficiency and reducing turnaround time,” the report stated. “Autonomous haulage systems control and track mining vehicle movements, coordinates and autonomously drives off-highway haul trucks operating in a mine. This system increases efficiency by minimizing delays, reducing operating costs and reducing fuel consumption, thereby minimizing carbon emissions. “With increase in mining projects and development of technology, the scope and potential for the global uranium ore mining market is expected to significantly rise in the forecast period,” the report concluded. With nuclear energy expected to see strong growth in the coming years as nations around the world work to provide affordable, sustainable clean energy, Energy Fuels looks to be in an ideal position. The company is the leading producer of uranium, the fuel for carbon- and emission-free nuclear energy, in the country. UUUU is also a major U.S. producer of vanadium and just began commercial production at its mill in Utah of an intermediate rare earth element product, the most advanced rare earth material being produced in the U.S. today. Energy Fuels has more uranium production capacity, licensed mines and processing facilities, and in-ground uranium resources than any other U.S. uranium producer. It boasts diverse cashflow-generating opportunities, including vanadium production, uranium recycling and rare earth processing. For more information, visit the company’s website at www.EnergyFuels.com. NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

Date: December 1-2, 2021 Venue: Virtual Event Q1 Production’s premier event platform offers a refreshing and unparalleled virtual experience. Thoughtfully designed and customizable networking features foster a sense of collaboration and discussion, allowing attendees to make direct connections. This program offers three half-day modules to maximize retention and engagement.

• Methods of application and influence of technological advancements
• AI Integration Automation Possibilities
• Regulatory operations teams and developing strategic skill sets
• Bridging the gap between associates at the junior and senior levels
• Dealing with changes in regulatory requirements and global considerations
• Keeping up with general industry developments
• Special considerations regarding emerging markets

Through resource management considerations, you will also look at the construction of submission dossiers and efficiency in optimizing the dossier preparation process, including technology and AI integration. The agenda of the conference includes: 

Time-Saving Strategies to Meet Accelerated Regulatory Submission Timelines

• Allocating resources and outsourcing decisions
• Prioritizing speed while retaining quality
• Best practices for large-scale dossier work

• Validations
• Hyperlinking
• Formatting data
• Hyperlinking Publishing

• Using automation to satisfy rising demand
• Having a positive influence on patients in need

Module 1 of the New eCTD fFr Electronic Submissions To The U.S. FDA

Form 2253 submission for promotional materials 

• Cross-functional training on regulatory and promotional rules
• Useful resources for additional learning and outreach
• Setting up a consistent procedure with the promotions department using FDA advice
• Forums and websites

The conference aims to establish parameters and educate people regarding: 

• Vendor selection and validation criteria
• Training and automation integration for support teams
• Demonstration of value proposition to offset upfront investment and measuring the gains in productivity due to automation

Hiring Conference

• A review of attributes regarding hiring of staff that have a high association to success
• Techniques to expand your search and effectively interview
• A spotlight on problems related to hiring and training personnel long-term talent acquisition and retention strategy

Who Will Benefit the Most from This Conference?

• Executives working in pharmaceutical companies who are currently working to implement eCTD 4.0 and newly added promotional submissions requirements
• Those who want to learn about viable automation solutions for workflow processes
• Those wanting to develop strategies around global submission timelines

This program will also help you to:

• Understanding your market and how it affects your submission strategy
• Take a seat at the early product operations decision-making table
• Take on compliance as a cross-functional responsibility
• Regulatory agenda advocacy across the organization

For more information about the event, please visit https://ibn.fm/x8g5z

• NCIA’s 7th Annual Cannabis Business Summit & Expo takes place December 15-17, 2021, at the Moscone Center in San Francisco.
• The event will showcase more than 80 educational sessions, 125-plus industry speakers, and hundreds of exhibitors under a single roof
• San Francisco Mayor, London Breed, will deliver welcome remarks at the conference on Thursday, December 16th at 10 a.m. PST.
• The Mayor’s appearance at the conference comes as the city celebrates the 30th anniversary of Proposition P, which legalized the use of medical cannabis in San Francisco in 1991.

The National Cannabis Industry Association (“NCIA”), widely recognized as the oldest, largest, and most influential trade association representing the legal cannabis business, will be hosting the 7th Annual Cannabis Business Summit & Expo on December 15-17, 2021. Taking place at San Francisco’s Moscone Center, the conference will showcase over 125 speakers, more than 80 educational sessions, and hundreds of exhibitors across a 12,000 square foot show floor.

The NCIA has recently revealed that San Francisco Mayor, London Breed, will deliver welcoming remarks at the conference, currently scheduled to take place at 10 a.m. PST on Thursday, December 16, 2021. Mayor Breed’s appearance at the 7th Annual Business Summit & Expo comes as San Francisco celebrates the 30th anniversary of the 1991 “Proposition P” ballot initiative, which was instrumental in legalizing the use of medical cannabis in San Francisco, as well as the 25th anniversary of California’s landmark Proposition 216, which extended medical legalization state-wide.

Elected to office in 2018, Mayor Breed, a lifelong member of the Democratic Party, has gained renown for her quest for a more equitable and just San Francisco for all. Thus far in her term, Mayor Breed has been instrumental in creating programs to extend shelter and care for the homeless, as well as provide affordable housing and workforce development programs, in her bid to ensure all San Franciscans have access to a thriving economy.

In addition to Mayor Beard’s appearance, the Cannabis Business Summit & Expo will also highlight cannabis industry leaders and activists, including Troy Datcher, Marvin Washington, Rachael Rapinoe, and Anna Symonds, who will be discoursing on a variety of topics in their positions as the event’s keynote speakers.

In addition, the event marks the debut of Bloom: A Brands Experience. The new “show within a show” entices attendees with a uniquely immersive sensory experience where they can see, touch, and smell products from dozens of brands specializing in flower, vapor, pre-roll, oils, edibles, and more, directly on the show floor

In addition to its keynote speakers, the Cannabis Business Summit will feature over 125+ speakers drawn from a wide range of cannabis sub-sectors. Conference attendees will have the chance to learn about a variety of topics, including ’The Cannabis Law Regulatory Rounds,’ ‘Cannabis Market Trends & Consumer Insights,’ ‘Pathway to Federal Legalization: An Update From DC,’ and ‘A Deep Dive into the Newly Recalibrated Cannabis M&A Market,’ among many others.

Renowned for its reputation as one of the cannabis industry’s most influential B2B trade shows, and the only event to combine a line-up of exclusive educational opportunities, exhibitors, and experiences under a single roof, this year’s Cannabis Business Summit & Expo promises to be a truly unmissable event. In addition, licensed retailers, distributors, infused product manufacturers, and cultivators with a valid state license may attend on a complimentary basis.

For more information about the Cannabis Business Summit & Expo and event registration, visit https://cannabisbusinesssummit.com

Date: November 30-December 2, 2021 Live Streaming Event Traders, shareholders, businesses, financial heads, and investment experts are invited to attend the MoneyShow Canada Virtual Expo being held from November 30- December 2, 2021, as a live streaming event. MoneyShow has been organizing conferences and seminars for over 40 years with a 100,000+ community of investors, financial heads, and businesses looking to gain knowledge and guidance about the latest investment tools, financial trends and opportunities from the stalwarts of the financial arena. The event boasts of a productive platform where attendees can take stock of the trending market ideas, stock picks, live sector analysis, and trade ideas from 30+ top finance market influencers. Traders and businesses can avail this opportunity to find numerous thriving avenues in the stock market for protection and profit. The event can be accessed LIVE from the comfort of one’s home, free of cost. The interactive virtual booths feature message boards, timely research, educational videos, exclusive discounts, prize drawings, and activities that keep the attendees engaged and interested all along! The MoneyShow Canada Virtual Expo is organized for Canadian investors of different skill levels who want to invest across a spectrum of investment sectors. The areas of discussions include a huge gamut of topics including market moves to make before 2022, inflation defence strategies, precious metals, tech and healthcare stocks, timely updates on the economy, and navigating the new normal post-pandemic. Important topics include:

• The Current State of the Economy and Top Stock Picks
• Investing in Real Estate Amid an Economic Recovery
• How to Find Yield in a Low-Rate Environment
• How to Trade Options and Generate a Profitable Income Stream
• When Does a Commodities Boom Turn Into a Supercycle?
• Why Clean Energy Stocks Could Get a Big Boost in 2022
• Navigating Volatility with Fixed-Income Strategies
• Why 2022 Could Be a Big Year for the Cannabis Industry

Get real-time access to the financial stalwarts and industry leaders who will share their ideas, views, and insights in LIVE presentations. New investors can leverage this event as a networking opportunity to build their financial relationships and chat directly with experts and fellow investors. Participants will get access to viewing global market experts and get their queries answered by them and learn new strategies of investments for the upcoming times. For more details on the event please visit https://ibn.fm/R8v0j

• Market analysts place high hopes on the potential of the United Kingdom market
• Growing demand from patients and patient families brought the country’s medical cannabis program to a tipping point
• RYAH is committed to providing valuable insight and transforming patient care through big data and artificial intelligence

After three years of medical cannabis being legal in the United Kingdom, the country has a total of only three patients with a prescription in the entire public system, noted a recent blog from RYAH Group (CSE: RYAH). The article noted that many more patients receive cannabis-derived medications, including flower and cannabis oil, through a growing number of private clinics (https://ibn.fm/mWT2d). The blog provided an overview of the market, observing that “market analysts continue to place high hopes on the potential of the UK market. Yet, in its current form, there remains significant room for improvement to the UK system. With little to no access through the public system and the radically expensive costs associated with privately supplied medical cannabis, many patients are desperate for prescriptions,” RYAH observed. “With growing calls from patients and patient families, the UK’s medical cannabis program is at a tipping point once again. The article pointed out that access to medical cannabis is restrictive in the country, with patients obtaining initial prescriptions through a specialist consultant rather than their general practitioners. Regulations also require patients to try at least two non-cannabis treatments before being eligible for a prescription, which can potentially mean months, if not years, of trial and error before a patient may qualify, the company reported. However, “the most challenging condition within the UK’s medical cannabis policies is the requirement for published evidence,” the blog states. “Medical cannabis may only be prescribed if there is published scientific support for its therapeutic benefits. Most people familiar with cannabis research will appreciate the complications caused by this policy. Patient access around the world suffers because there is a lack of research.” The country is ready for change, RYAH reports. “In 2020, Prohibition Partners suggested the UK market could reach £2.31 billion ($3.13 billion US) by 2024. Statista offered an updated estimate in 2021, predicting the market would hit $1.29 billion US by 2024. At the current pace, these numbers seem unattainable. But change is coming. “The UK public is firmly behind medical cannabis, with more than three-quarters supportive of legal access,” the article continued. “With the growing public outcry following continued reports that the government is refusing access to this valuable therapy, change is in the air.” The leading data technology company in plant-based medicine, RYAH is committed to providing valuable insight and transforming patient care through big data and artificial intelligence. The company is working to unearth breakthrough discoveries that will reshape the understanding of plant-based medicines. For more information, visit the company’s website at www.RYAHGroup.com. NOTE TO INVESTORS: The latest news and updates relating to RYAH are available in the company’s newsroom at https://ibn.fm/RYAH

• Plant-based food consumers are a growing market sector, increasing their purchases at a rate almost 2.5 times the growth of the overall foods market during the past two years
• Plant-based community brand builder PlantX Life Inc. is becoming a growing global presence as part of its efforts to become a one-stop shopping source of products and information about the plant-based lifestyle
• PlantX has physical store presence in Canada and the U.S., as well as one in Israel that will open before the end of the year
• The company’s e-commerce platform recently added a subscription service that caters to recurring customer services, providing discounts for automatically renewable weekly, biweekly, or monthly product shipments
• PlantX has recruited 18 social media influencers to help it market its brand to a larger segment of consumers
• The company uses a weekly podcast series, YouTube channel videos and an informative blog to help build education about the ecosystem among like-minded fans of the lifestyle

Plant-based lifestyle e-retailer and educator PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) recently announced the expansion of its online sales offerings to include discounts for shoppers who subscribe for recurring service. The Nov. 22 announcement states customers who arrange automatic fulfillments for recurring deliveries of any product on the PlantX website will be able to design personalized shopping plans for their favorite products with a weekly, biweekly or monthly refresher. “The new subscription service aims to overcome potential barriers to a healthy lifestyle such as time and cost,” PlantX Founder Sean Dollinger stated (https://ibn.fm/2SMXG). PlantX’s focus on serving the interests of the plant-based community and providing education about its lifestyle benefits to those exploring it in North America are helping the company tap into a relatively new and growing food industry. Plant-based food dollar sales grew 43 percent in the past two years, at a rate almost 2.5 times faster than total food sales from 2018 to 2020, according to a report issued by Good Food Institute analysts earlier this year. The report found that the retail market for plant-based foods has risen to $7 billion, penetrating 57 percent of U.S. households (https://ibn.fm/qOBPj). Bloomberg Intelligence valued the global market for plant-based foods at $29.4 billion in 2020 and predicted that it will exceed $162 billion within the next decade, growing at a rate of 451 percent (https://ibn.fm/PGRD7). PlantX launched a new initiative this year to market itself to those consumers adopting aspects of the plant-based wellness lifestyle, drawing on the power of social media to get its brand more squarely in front of shoppers. The company has engaged select “micro-influencers” on social media platforms including TikTok and Twitter, hiring 18 influencers for limited periods to post content and provide coverage of PlantX news releases to their dedicated audiences. “We live in a time where brands and companies can significantly boost their popularity with viral content focused on social media apps,” PlantX Chief Marketing Officer Alex Hoffman stated in the Nov. 22 announcement. In addition to its e-commerce sales, PlantX has been expanding its XMarket retail store outlets, recently celebrating the grand opening of a store in the San Diego area and another in Venice Beach, which add to the company’s flagship store and dining outlet in Squamish, British Columbia. Additional stores are expected soon in Tel Aviv, Israel, and in Toronto and Ottawa, Canada (https://ibn.fm/W8E41). As part of its efforts to become the plant-based community’s go-to one-stop-shopping hub, PlantX’s educational efforts have grown to include a weekly podcast, blog and YouTube presence, where tips on healthy diet choices, plant-growing wisdom and how to understand the ecosystem of the growing community abound. For more information, visit the company’s websites at www.PlantX.com, www.PlantX.ca, and https://investor.plantx.com/ and view PlantX for Plant-Based Investors. NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF